PMS19 - A BUDGET IMPACT ANALYSIS OF INTRODUCING A FORCED TREATMENT PATHWAY USING THE LOWEST PRICED ANTI-TUMOR NECROSIS FACTOR AGENT FOR RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS IN THE PHILIPPINES

Autor: Tee, M., Tee, C.A.
Zdroj: In Value in Health October 2018 21 Supplement 3:S290-S291
Databáze: ScienceDirect